09. COPD, Emphysema, Chronic Bronchitis, Alpha-1 Antitrypsin Deficiency -> Adult -> Clinical Studies

GDF-15, Pentraxin-3 and TIMP-1 Plasma Biomarkers Improve Risk Assessment for Mortality in Ambulatory Veterans with COPD

Poster Board Number
809
Presenter:
  • B. Masters
Session Number
B24
Session Title:
B24 - BIOMARKERS IN COPD
Session Type:
Poster Discussion Session
Authors
  • B. Masters
  • G. Urdaneta
  • I. Vital
  • M. Campos
  • M. Miller
  • J. Herrera
Video Upload

Previous Eposter
Biomarkers to Predict Forced Expiratory Volume in 1 Second (FEV1) Decline in Healthy Smokers and Early-Onset Chronic Obstructive Pulmonary Disease (COPD)

Next Eposters
Cardiovascular Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Chronic Obstructive Pulmonary Disease (COPD): A 24-Hour Holter Monitoring Sub-Study of the ETHOS Trial
Chronic Obstructive Pulmonary Disease Plus (COPD+)® as a Friendly App for Patients with Chronic Obstructive Pulmonary Disease
Insights from Mid-Expiratory Flow Rate (FEF25-75%) in Ever-Smokers with Preserved Lung Function in the Subpopulations and Intermediate Markers in COPD Study (SPIROMICS) Cohort
Club Cell Protein-16 (CC16) Is Reduced in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Relationship of Dorsal Hyperkyphosis with Quality of Life in Patients with COPD in Northeastern Colombia
Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations
Under-Representation of Women in the Evidence Base for COPD Management
Continuous Auscultation Versus Intermittent Auscultation in Determining the Presence of Wheezes in Patients Presenting with Asthma or COPD Exacerbation
Comparison of Abnormal Respiratory Sounds and Peak Expiratory Flow Measurements in Patients Presenting to the Emergency Room with Acute Exacerbation of Asthma or COPD
Evaluation of Clinical Outcomes Within Baseline Exacerbation Subgroups Among Patients with COPD Initiating Combination Tiotropium/Olodaterol Versus Triple Therapy